Wells Fargo’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-944,700
Closed -$59.4M – 7674
2023
Q3
$59.4M Buy
+944,700
New +$58.8M 0.02% 613
2020
Q1
– Sell
-62,500
Closed -$119K – 6564
2019
Q4
$119K Buy
+62,500
New +$3.02M ﹤0.01% 5215
2019
Q1
– Sell
-150,000
Closed -$7K – 6299
2018
Q4
$7K Sell
150,000
-200,000
-57% -$8.58M ﹤0.01% 6019
2018
Q3
$185K Buy
350,000
+237,100
+210% +$10.8M ﹤0.01% 5045
2018
Q2
$5K Buy
+112,900
New +$5.26M ﹤0.01% 6084
2018
Q1
– Sell
-85,000
Closed -$230K – 6487
2017
Q4
$230K Hold
85,000
– – ﹤0.01% 4890
2017
Q3
$401K Sell
85,000
-4,760
-5% -$232K ﹤0.01% 4473
2017
Q2
$310K Buy
89,760
+17,728
+25% +$822K ﹤0.01% 4513
2017
Q1
$307K Sell
72,032
-40,168
-36% -$1.91M ﹤0.01% 4550
2016
Q4
$77K Buy
+112,200
New +$5.15M ﹤0.01% 5257

Other funds holding MET

Wells Fargo's MET Position: Q2 2026 in Review

Wells Fargo reduced its MetLife (MET) stake by 6% in Q2 2026, selling an estimated $7.53M and leaving 1,450,511 shares worth $123M. The position accounts for 0.02% of the portfolio, ranked #584.

Wells Fargo first reported a position in MET in Q2 2013 and has held it in 53 quarters since. The position peaked at $353M in Q2 2017. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Wells Fargo held 1,450,511 shares of MetLife worth $123M as of Q2 2026.
  • Wells Fargo sold 93,333 MetLife shares in Q2 2026, an estimated $7.53M.
  • MetLife made up 0.02% of Wells Fargo's portfolio in Q2 2026, its #584 holding.
  • Wells Fargo first reported a position in MetLife in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's MetLife position peaked at $353M in Q2 2017.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.